Thinking about cancer or dealing with cancer risk can be scary or overwhelming, but we believe that receiving information and resources is comforting, empowering, and lifesaving.
Oophorectomy Surgical Checklist
FORCE has compiled this list of suggestions from volunteers to help women prepare for oophorectomy surgery.
The Pros and Cons of Hysterectomy at the Time of Risk-reducing Removal of Ovaries and Fallopian Tubes
2014 webinar by Jessica McAlpine, MD of the University of British Columbia, outlining the proc and cons of hysterectomy during risk-reducing surgery to remove the ovaries and tubes.
How Do Women Decide Whether Or Not To Remove Their Uterus During BSO?
Article on results from FORCE survey on factors that impact women's decisions on whether or not to remove their uterus during BSO.
Is Risk of Uterine Cancer Increased in BRCA Mutation Carriers?
2014 FORCE review of research on possible link between BRCA 1 and certain types of uterine cancer.
Can removing the fallopian tubes lower ovarian cancer risk?
2013 webinar by Drs. Doug Levine from Memorial Sloan Kettering and Ilana Cass from Cedar-Sinai Medical Center on whether removal of the fallopian tubes can lower the risk for ovarian cancer.
Confronting Hereditary Breast and Ovarian Cancer
This FORCE-endorsed book was written by founder and Executive Director Sue Friedman; geneticist Rebecca Sutphen, MD; and health writer, Kathy Steligo. This book is a comprehensive resource on all topics related to hereditary cancer, genetic testing, and risk-management.
Patient Experience Contact Tool
The Patient Experience Contact Tool is a searchable database of surgeons and related health-care providers that have been used by members of our community. The tool is provided to allow patients to connect one to one and share their experiences about their experiences.
GOG-0199: The National Ovarian Cancer Prevention and Early Detection Study
Article from Spring 2012 Joining FORCEs Newsletter with updates on the research from GOG-199, a large, multicenter study on ovarian cancer detection and prevention.
Does ovarian cancer start in the fallopian tubes? How does this affect screening and prevention?
2011 Webinar. Dr. Kauff discusses the latest research and expert opinions on whether most hereditary ovarian cancer begins in the fallopian tubes and approaches to ovarian cancer screening based on these findings
Risk Reducing Surgery Lowers Likelihood of Breast and Ovarian Cancer; Decreases Mortality of BRCA and BRCA Mutation Carriers
Spring 2011 Newsletter article on research that links prophylactic BSO to lower mortality in BRCA mutation carriers.
What is Pelvic Health Rehabilitation?
Fall 2012 newsletter article on how pelvic health rehabilitation can help with post-oophorectomy recovery and side effects from surgical menopause.
Dr. Susan Love's Menopause & Hormone Book
Dr. Susan Love
I'm Not in the Mood: What Every Woman Should Know About Improving Her Libido
by Judith Reichman
Restore Yourself: A Woman's Guide to Reviving her Sexual Desire and Passion for Life
by James A. Simon, M.D., and Victoria Houston
Decision Tool for Women with BRCA Mutations
Developed by researchers at Stanford University, this tool is designed to help women with BRCA mutations understand the risks and survival benefits for each risk-management option in order to make the decision that is right for them.
Fertile Hope is a nonprofit organization providing information and support for cancer patients whose medical treatments may affect their fertility. The website provides a wide range of information as well as links to organizations, selected health care providers, and other resources.
Hyster Sisters is an online support site for women facing hysterectomy or gynecologic surgery.
North American Menopause Society
NAMS is a scientific organization devoted to promoting women's health and quality of life through an understanding of menopause.
Women's Cancer Network
Sponsored by the Gynecologic Cancer Foundation, the Women’s Cancer Network has excellent overviews about ovarian cancer and links to finding a gynecologic-oncologist.